1. Home
  2. EYPT vs PFIS Comparison

EYPT vs PFIS Comparison

Compare EYPT & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • PFIS
  • Stock Information
  • Founded
  • EYPT 1987
  • PFIS 1905
  • Country
  • EYPT United States
  • PFIS United States
  • Employees
  • EYPT N/A
  • PFIS N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • PFIS Major Banks
  • Sector
  • EYPT Industrials
  • PFIS Finance
  • Exchange
  • EYPT Nasdaq
  • PFIS Nasdaq
  • Market Cap
  • EYPT 439.4M
  • PFIS 441.9M
  • IPO Year
  • EYPT 2005
  • PFIS N/A
  • Fundamental
  • Price
  • EYPT $9.17
  • PFIS $52.37
  • Analyst Decision
  • EYPT Strong Buy
  • PFIS Hold
  • Analyst Count
  • EYPT 8
  • PFIS 1
  • Target Price
  • EYPT $27.29
  • PFIS $47.00
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • PFIS 22.8K
  • Earning Date
  • EYPT 11-07-2024
  • PFIS 11-05-2024
  • Dividend Yield
  • EYPT N/A
  • PFIS 4.72%
  • EPS Growth
  • EYPT N/A
  • PFIS N/A
  • EPS
  • EYPT N/A
  • PFIS 0.78
  • Revenue
  • EYPT $45,713,000.00
  • PFIS $96,196,000.00
  • Revenue This Year
  • EYPT N/A
  • PFIS N/A
  • Revenue Next Year
  • EYPT N/A
  • PFIS $35.97
  • P/E Ratio
  • EYPT N/A
  • PFIS $67.53
  • Revenue Growth
  • EYPT 7.50
  • PFIS N/A
  • 52 Week Low
  • EYPT $5.86
  • PFIS $36.26
  • 52 Week High
  • EYPT $30.99
  • PFIS $55.64
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 38.25
  • PFIS 61.18
  • Support Level
  • EYPT $11.26
  • PFIS $50.62
  • Resistance Level
  • EYPT $12.23
  • PFIS $54.00
  • Average True Range (ATR)
  • EYPT 0.97
  • PFIS 1.94
  • MACD
  • EYPT -0.30
  • PFIS 0.36
  • Stochastic Oscillator
  • EYPT 3.24
  • PFIS 64.50

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About PFIS Peoples Financial Services Corp.

Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.

Share on Social Networks: